
Dual-Mode Treatment of Hepatocellular Carcinoma Using RGD Cyclopeptide-Modified Liposomes Loaded with Ce6/DOX
Introduction Hepatocellular carcinoma (HCC) represents 80% of all primary liver cancers worldwide and is the sixth most common cancer and the third leading cause of cancer-related deaths.1 Due to the typically late appearance of symptoms, more than half of …